Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALNY

Alnylam Pharmaceuticals Inc

298.76

Jul 10 • 04:00PM ET -14.03 (-4.49%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX AMGN GILD BIIB BMRN ONC ABBV LLY

| Held by: VTI QQQ VO VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX
Market Cap	39.89B
Enterprise Value	39.85B
Income	577.22M
Sales	4.29B
Book/sh	8.06
Cash/sh	22.54
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	70.99
Forward P/E	27.99
PEG	0.35
P/S	9.30
P/B	37.07
P/C	13.26
P/FCF	62.20
EV/EBITDA	49.38
EV/Sales	9.30
Quick Ratio	3.06
Current Ratio	3.13
Debt/Eq	2.76
LT Debt/Eq	2.51
Option/Short	Yes / Yes

EPS (ttm)	4.21
EPS next Y	10.67
EPS next Q	1.61
EPS this Y	218.43%
EPS next Y	43.86%
EPS next 5Y	80.73%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	308.45%
Sales Y/Y TTM	82.57%
EPS Q/Q	440.32%
Sales Q/Q	96.43%
Earnings	Apr 30 BMO
EPS/Sales Surpr.	73.26% 4.63%

Insider Own	0.43%
Insider Trans	-12.23%
Inst Own	98.88%
Inst Trans	0.01%
ROA	12.36%
ROE	96.94%
ROIC	15.30%
Gross Margin	80.83%
Oper. Margin	17.54%
Profit Margin	13.46%
SMA20	0.68%
SMA50	0.79%
SMA200	-17.79%
Trades

Shs Outstand	133.44M
Shs Float	132.94M
Short Float	4.36%
Short Ratio	4.82
Short Interest	5.80M
52W High	495.55 -39.71%
52W Low	273.11 9.39%
Volatility	8.14% 4.45%
ATR (14)	15.40
RSI (14)	48.69
Beta	0.27
Rel Volume	2.11
Avg Volume	1.20M
Volume	2,538,065

Perf Week	-4.48%
Perf Month	0.36%
Perf Quarter	-7.01%
Perf Half Y	-29.29%
Perf YTD	-24.87%
Perf Year	-7.40%
Perf 3Y	49.52%
Perf 5Y	69.04%
Perf 10Y	380.48%
Recom	1.67
Target Price	446.43
Prev Close	312.79
Price	298.76
Change	-4.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)